Navigation Links
Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, etc.) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Date:11/9/2013

Albany, New York, USA (PRWEB) November 09, 2013

According to a new market report published by Transparency Market Research "Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global companion diagnostics market was valued at USD 1.8 billion in 2012 and is expected to grow at a CAGR of 18.1 percent from 2013 to 2019, to reach an estimated value of USD 5.6 billion in 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/companion-diagnostics-market.html.

Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with the drug in development. The diagnostic test acts as a companion to the drug under investigation and ensures the commercialization of a safer and efficient targeted therapeutic in a very cost-effective manner. The most important factors favoring growth of the global companion diagnostics market include the increasing focus of pharmaceutical manufacturers on cost reduction in drug discovery and development, and the rising demand for targeted therapies. Also, continuous exploration of biomarkers and advances in diagnostic technologies will drive the growth and acceptance of companion diagnostics worldwide.

Factors such as lack of compact regulatory guidelines for the development and commercialization of companion diagnostics, high cost of procedures, lengthy developmental and approval phases, and lack of proper reach and availability (particularly in the low income countries) are expected to hamper the ready acceptance of companion diagnostics. Currently, many in vitro diagnostics companies are focusing on the development of accurate and reliable companion diagnostics for various biomarkers.

Pharmaceutical companies are either focusing on in-house development of companion diagnostics or development in collaboration with diagnostics companies. This strategy focusing on the co-development of a drug and its companion diagnostic will prove to be advantageous over the conventional development process occurring in isolation.

Related Report : Noninvasive Prenatal Diagnostics Market
http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year.

The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). The report also contains a section on market overview which consists of a detailed qualitative analysis of various market dynamics, such as drivers, restraints and opportunities. A section on market attractiveness analysis and Porter’s five force analysis for the companion diagnostics market has also been included.

Browse Blog: http://www.tmrblog.com/
Browse all Market Research reports: http://www.transparencymarketresearch.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11311896.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
2. Global Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment Research Report
3. The Perfect Travel Companion Uncovered: Launching Tisseron Lightweight Velour Bathrobes
4. Global Companion Diagnostics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
5. BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
6. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com
7. Mayo Clinic and SV Bio enter strategic relationship on genome diagnostics and interpretation
8. Diagnostic Marketing Association Names Siemens Healthcare Diagnostics its 2012 Marketer of the Year
9. Advanced Mold Diagnostics Receives Angie's List Super Service Award for 4th Straight Year
10. ORNLs awake imaging device moves diagnostics field forward
11. Penn Medicines new center for personalized diagnostics unlocks cancers secrets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... , ... Japanese Zen artist couple, Fumie and Kentaro Mune, have announced to ... at Miranda Kuo Gallery on Lower East Side, NYC. This exhibition will feature some ... Wanderlust , one of the largest US yoga online media outlets in the world, ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... serving communities in northern Alabama and Georgia, is embarking on an extended charity ... utilizing modern early detection methods. , US Breast Cancer statistics show that ...
(Date:9/20/2017)... ... 2017 , ... Collins Concrete Coatings announced that they offer ... safety and cleanliness. This unique flooring system uses silver ion technology to resist ... for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ions attack ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released a ... activities. , FDA is more adamant than ever about medical device, pharmaceutical, ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... innovation, the company recently unveiled a redesigned website. The new site – still ... of building owners, architects, contractors and other industry users that Garland serves. , ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical stage ... Ideation and Behavior (ASIB), has been granted Fast Track status ... therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + ... pivotal trial of this sequential therapy targeting patients who are ... ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
(Date:9/1/2017)... , Sept. 1, 2017  Explorers Like Us ( ... America,s greatest aural experiences — and deliver these experiences as ... to help people feel and heal better. ... While nothing beats a walk, ... refresh your mind, Life Environments™ is the next best thing ...
Breaking Medicine Technology: